Effect of Renal Impairment on the Pharmacokinetics of Pradigastat, a Novel Diacylglycerol Acyltransferase1 (DGAT1) Inhibitor

被引：0
|
作者：
Sachiko Mita
Dan Meyers
Parasar Pal
TsuHan Lin
Tapan Majumdar
Sam Rebello
Gangadhar Sunkara
Jin Chen
机构：
[1] Novartis Pharma K.K.,
[2] Novartis Institutes for BioMedical Research,undefined
[3] Novartis Healthcare Private Limited,undefined
[4] Alcon Laboratories,undefined
[5] Inc.,undefined
[6] Novartis Institutes for BioMedical Research,undefined
来源：
Clinical Pharmacokinetics | 2015年 / 54卷
关键词：
Pharmacokinetic Parameter; Renal Impairment; Severe Renal Impairment; Moderate Renal Impairment; Matched Healthy Control;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：751 / 760
页数：9
相关论文
共 50 条
  • [21] Diacylglycerol acyltransferase 1 (DGAT1) inhibition by furofuran lignans from stems of Acanthopanax senticosus
    Li, Ban-Ban
    Li, Jia-Lin
    Li, Na
    Qi, Shi-Zhou
    Lee, Hyun-Sun
    Zhang, Le
    Xing, Shan-Shan
    Tuo, Zhen-Dong
    Cui, Long
    ARCHIVES OF PHARMACAL RESEARCH, 2017, 40 (11) : 1271 - 1277
  • [22] Diacylglycerol acyltransferase-1 (DGAT1) improves in vitro embryo development and quality in bovine
    Giraldo-Giraldo, J.
    Canon-Beltran, K.
    Cajas, Y. N.
    Vasquez, N.
    Leal, C. L. V.
    Gonzalez, M. E.
    Rizos, D.
    REPRODUCTION IN DOMESTIC ANIMALS, 2019, 54 : 122 - 122
  • [23] DIACYLGLYCEROL ACYLTRANSFERASE1 Contributes to Freezing Tolerance
    Arisz, Steven A.
    Heo, Jae-Yun
    Koevoets, Iko T.
    Zhao, Tao
    van Egmond, Pieter
    Meyer, A. Jessica
    Zeng, Weiqing
    Niu, Xiaomu
    Wang, Baosheng
    Mitchell-Olds, Thomas
    Schranz, M. Eric
    Testerink, Christa
    PLANT PHYSIOLOGY, 2018, 177 (04) : 1410 - 1424
  • [24] FUNCTIONAL ANALYSIS OF THE DIACYLGLYCEROL ACYLTRANSFERASE ACTIVITY-1 (DGAT1) IN THE REPLICATION OF HEPATITIS C VIRUS: EFFECT OF QUERCETIN
    Rojas, A.
    Garcia-Valdecasas, M.
    del Campo, J. A.
    Romero-Gomez, M.
    JOURNAL OF HEPATOLOGY, 2013, 58 : S476 - S477
  • [25] Triazolo compounds useful as diacylglycerol acyltransferase1 inhibitor-WO2009126624
    Matsuda, Daisuke
    Tomoda, Hiroshi
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2010, 20 (08) : 1097 - 1102
  • [26] Current Status of the Research and Development of Diacylglycerol O-Acyltransferase 1 (DGAT1) Inhibitors Miniperspective
    DeVita, Robert J.
    Pinto, Shirly
    JOURNAL OF MEDICINAL CHEMISTRY, 2013, 56 (24) : 9820 - 9825
  • [27] Effect of Pradigastat, a Diacylglycerol Acyltransferase 1 Inhibitor, on Liver Fat Content in Nonalcoholic Fatty Liver Disease
    Sanyal, Arun J.
    Cusi, Kenneth
    Patel, Samir
    Wright, Melanie
    Liu, Changlu
    Keefe, Deborah L.
    HEPATOLOGY, 2015, 62 : 1253A - 1253A
  • [28] Impaired mammary gland development in mice lacking acyl CoA:diacylglycerol acyltransferase 1 (DGAT1)
    Cases, S
    Zhou, P
    Wiseman, B
    Fish, JD
    Werb, Z
    Farese, RV
    FASEB JOURNAL, 2003, 17 (04): : A449 - A449
  • [29] Effect of the DGAT1 inhibitor pradigastat on triglyceride and apoB48 levels in patients with familial chylomicronemia syndrome
    Charles Daniel Meyers
    Karine Tremblay
    Ahmed Amer
    Jin Chen
    Liewen Jiang
    Daniel Gaudet
    Lipids in Health and Disease, 14
  • [30] Effect of the DGAT1 inhibitor pradigastat on triglyceride and apoB48 levels in patients with familial chylomicronemia syndrome
    Meyers, Charles Daniel
    Tremblay, Karine
    Amer, Ahmed
    Chen, Jin
    Jiang, Liewen
    Gaudet, Daniel
    LIPIDS IN HEALTH AND DISEASE, 2015, 14
12345